Join Sandy Srinivas, MD and Alexey Aleshin, MD, MBA from Stanford Cancer Institute as they present their expertise on a range of cases pertaining to metastatic prostate cancer.

The 2016 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of colorectal cancer, prostate cancer, distress management, CML, ovarian cancer, and multiple myeloma.

The 2016 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of colorectal cancer, prostate cancer, distress management, CML, ovarian cancer, and multiple myeloma.

The goal of this activity is to increase participants' ability to leverage recent developments in the care of patients with advanced prostate cancer to improve clinical outcomes and quality of life.

Join Andrew J. Armstrong, MD, ScM and Bridget Koontz, MD from Duke Cancer Institute as they present their expertise on a range of cases pertaining to castrate resistant prostate cancer (CRPC).

This information was originally presented at the NCCN 21^st Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida, from March 31 – April 2, 2016.

This information was originally presented at the NCCN 21^st Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida, from March 31 – April 2, 2016.

The goal of this activity is to increase participants' ability to leverage recent developments in the care of patients with advanced prostate cancer to improve clinical outcomes and quality of life.

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program.

Join Andrew J. Armstrong, MD, ScM and Bridget Koontz, MD from Duke Cancer Institute as they present their expertise on a range of cases pertaining to castrate resistant prostate cancer (CRPC).